AquaBounty 13M share Spot Secondary priced at $8.50 07:12 AQB Oppenheimer and Lake Street acted as joint book running managers for the offering.
ooops-
Penn National reports Q4 EPS 7c, consensus 24c
1Life Healthcare price target raised to $62 from $42 at Citi 07:08 ONEM Citi analyst Daniel Grosslight raised the firm's price target on 1Life Healthcare to $62 from $42 and keeps a Buy rating on the shares. The anlasayt thinks 1Life's "vital role" in helping with COVID-19 vaccine distribution and administration provides incremental upside to 2021 net patient revenue estimates and will serve as a catalyst for membership growth acceleration.
Stony's PIPE stock--
Advanced Drainage reports Q3 EPS 62c, consensus 47c 06:51 WMS Reports Q3 revenue $486.1M, consensus $407.9M. CEO Scott Barbour commented, "We delivered a record Q3 in FY21. Sales grew 24% year-over-year, driven by 17% non-residential sales growth and 36% residential sales growth as we continued to execute on our material conversion strategy in the favorable demand environment. We experienced strong demand in key growth states in the South and Southeast regions of the U.S., as well as the return of demand in the Western and Northeast regions of the U.S. In addition, sales in the agriculture market increased 33%, driven by the programs we put in place around organizational changes, new product introductions and improving execution in the strong fall selling season. Overall, we executed well this quarter to meet the growing demand for our products and solutions and continue to benefit from our national presence as well as our favorable geographic and end market exposure. We also achieved record profitability in Q3. Our Adjusted EBITDA margin expanded 540-basis points this quarter, our first full quarter of comparable results from the Infiltrator business. In addition to capturing the benefits of leverage from our strong sales growth, both companies successfully offset inflationary costs through favorable pricing, operational productivity initiatives and our synergy programs. As we move toward the end of our fiscal year, we are optimistic about our business outlook as our order book, project tracking, book-to-bill ratio and backlog continue to be favorable on a year-over-year basis. We are well positioned to capitalize on growing residential development and horizontal construction, while continuing to generate above-market growth through the execution of our material conversion and water management solutions strategies".
